Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX): Forecast Weak In 2024, Up -26.85%

The trading price of Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) floating higher at last check on Tuesday, May 15, closing at $6.41, 19.68% higher than its previous close.

In examining the 52-week price action we see that the stock hit a 52-week high of $8.96 and a 52-week low of $4.03. Over the past month, the stock has gained 39.15% in value.

Biocryst Pharmaceuticals Inc., whose market valuation is $1.32 billion at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -0.17 per share this quarter, however they have predicted annual earnings per share of -0.6 for current year and -0.34 for next year.

Analysts have forecast the company to bring in revenue of 98.47M for the current quarter, with the likely lows of 96.66M and highs of 101.09M. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 402.57M.

On the technical side, indicators suggest BCRX has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 50% Buy.

A quick review shows that BCRX’s price is currently 36.47% off the SMA20 and 31.25% off the SMA50. The RSI metric on the 14-day chart is currently showing 73.04, and weekly volatility stands at 8.48%. When measured over the past 30 days, the indicator reaches 6.95%. Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX)’s beta value is currently sitting at 1.81, while the Average True Range indicator is currently displaying 0.43.

To see how Biocryst Pharmaceuticals Inc. stock has been performing today in comparison to its peers in the industry, here are the numbers: BCRX stock’s performance was 19.68% at last check in today’s session, and -26.85% in the past year.

An evaluation of the daily trading volume of Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) indicates that the 3-month average is 3.38 million.

Currently, records show that 205.77 million of the company’s shares remain outstanding. The insiders hold 3.68% of outstanding shares, whereas institutions hold 83.36%. However, since the stock’s price has seen 7.10% year-to-date, investors’ interest is likely to be reignited due to its potential to move even higher.

Most Popular